Millrace Asset Group’s TELA Bio TELA Stock Holding History

Millrace Asset Group’s Portfolio TELA Stock Details TELA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-53,197	Closed	-$880K	–	87
2020 Q3	$880K	Sell	53,197 -38,157	-42%	-$536K	0.71%	66
2020 Q2	$1.18M	Buy	+91,354	New	+$1.2M	1.21%	42

Other funds holding TELA

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Millrace Asset Group's TELA Position: Q4 2020 in Review

Millrace Asset Group sold out of TELA Bio (TELA) in Q4 2020, closing a stake of 53,197 shares — an estimated $880K sold.

Millrace Asset Group first reported a position in TELA in Q2 2020 and held it in 2 quarters. The position peaked at $1.18M in Q2 2020. 47 funds tracked by Wall St. Rank hold TELA as of Q4 2020.

Millrace Asset Group reported no remaining TELA Bio position as of Q4 2020 after selling out during the quarter.
Millrace Asset Group sold 53,197 TELA Bio shares in Q4 2020, an estimated $880K.
Millrace Asset Group first reported a position in TELA Bio in Q2 2020 and held it in 2 quarters.
Millrace Asset Group's TELA Bio position peaked at $1.18M in Q2 2020.
47 funds tracked by Wall St. Rank held TELA Bio as of Q4 2020.

Based on Millrace Asset Group's 13F filing for Q4 2020, filed 11 Feb 2021.